Smokeless tobacco, good or bad?

NewsGuard 100/100 Score

Should the health community promote smokeless tobacco (snus) as a harm reduction measure?

In a debate in this week's PLoS Medicine, public health researchers discuss whether or not the public should be informed that using oral, smokeless tobacco (Swedish snus) is less hazardous to health than smoking tobacco.

Arguing the case for providing such information, Carol Gartner and Wayne Hall (University of Queensland, Australia) point to the Swedish experience. Snus seems to be widelyused as an alternative to cigarettes in Sweden, contributing to the low overall prevalence of smoking and smoking-related disease. "On the Swedish experience," say Gartner and Hall, "there is a strong prima facie case on public health and ethical grounds for recommending snus to inveterate smokers who want to reduce their health risks and for considering public policies, such as lower taxes for snus and public information campaigns, to promote its use by smokers."

However, Simon Chapman and Becky Freedman (University of Sydney, Australia) argue that Sweden's experience is likely to be specific to that culture and not transferable to other settings, and that if tobacco companies are allowed to market snus they will undoubtedly use the opportunity to promote tobacco as well. 'snus enthusiasts in the public health community," say Chapman and Freedman, "focus on snus" potential to take people away from smoking. However transnational tobacco companies are already marketing snus using slogans that mention smoking, such as: "When you can't smoke, snus."

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Varenicline dosage increase helps persistent smokers quit